Kulke MH - Search Results

1

Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus.

Yuan C, Rubinson DA, Qian ZR, Wu C, Kraft P, Bao Y, Ogino S, Ng K, Clancy TE, Swanson RS, Gorman MJ, Brais LK, Li T, Stampfer MJ, Hu FB, Giovannucci EL, Kulke MH, Fuchs CS, Wolpin BM. Yuan C, et al. Among authors: kulke mh. J Clin Oncol. 2015 Jan 1;33(1):29-35. doi: 10.1200/JCO.2014.57.5688. Epub 2014 Nov 17. J Clin Oncol. 2015. PMID: 25403204 Free PMC article.

2

A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.

Ryan DP, Kulke MH, Fuchs CS, Grossbard ML, Grossman SR, Morgan JA, Earle CC, Shivdasani R, Kim H, Mayer RJ, Clark JW. Ryan DP, et al. Among authors: kulke mh. Cancer. 2002 Jan 1;94(1):97-103. doi: 10.1002/cncr.10202. Cancer. 2002. PMID: 11815964 Free article. Clinical Trial.

3

A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer.

Kulke MH, Demetri GD, Sharpless NE, Ryan DP, Shivdasani R, Clark JS, Spiegelman BM, Kim H, Mayer RJ, Fuchs CS. Kulke MH, et al. Cancer J. 2002 Sep-Oct;8(5):395-9. doi: 10.1097/00130404-200209000-00010. Cancer J. 2002. PMID: 12416897 Clinical Trial.

4

Recent developments in the pharmacological treatment of advanced pancreatic cancer.

Kulke MH. Kulke MH. Expert Opin Investig Drugs. 2003 Jun;12(6):983-92. doi: 10.1517/13543784.12.6.983. Expert Opin Investig Drugs. 2003. PMID: 12783602 Review.

5

A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer.

Ryan DP, Clark JW, Kulke MH, Fuchs CS, Earle CC, Enzinger PC, Stuart K, Catarius KJ, Winkelmann J, Mayer RJ. Ryan DP, et al. Among authors: kulke mh. Cancer Invest. 2003;21(4):505-11. doi: 10.1081/cnv-120022359. Cancer Invest. 2003. PMID: 14533439 Clinical Trial.

6

A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.

Kulke MH, Kim H, Clark JW, Enzinger PC, Lynch TJ, Morgan JA, Vincitore M, Michelini A, Fuchs CS. Kulke MH, et al. Cancer. 2004 Sep 1;101(5):934-9. doi: 10.1002/cncr.20466. Cancer. 2004. PMID: 15329900 Free article. Clinical Trial.

7

A phase II study of docetaxel in patients with metastatic carcinoid tumors.

Kulke MH, Kim H, Stuart K, Clark JW, Ryan DP, Vincitore M, Mayer RJ, Fuchs CS. Kulke MH, et al. Cancer Invest. 2004;22(3):353-9. doi: 10.1081/cnv-200029058. Cancer Invest. 2004. PMID: 15493355 Clinical Trial.

8

Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.

McCollum AD, Kulke MH, Ryan DP, Clark JW, Shulman LN, Mayer RJ, Bartel S, Fuchs CS. McCollum AD, et al. Among authors: kulke mh. Am J Clin Oncol. 2004 Oct;27(5):485-8. doi: 10.1097/01.coc.0000135343.06038.eb. Am J Clin Oncol. 2004. PMID: 15596916

9

A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma.

Zhu AX, Fuchs CS, Clark JW, Muzikansky A, Taylor K, Sheehan S, Tam K, Yung E, Kulke MH, Ryan DP. Zhu AX, et al. Among authors: kulke mh. Oncologist. 2005 Jun-Jul;10(6):392-8. doi: 10.1634/theoncologist.10-6-392. Oncologist. 2005. PMID: 15967833 Free article. Clinical Trial.

10

Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer.

Ogino S, Meyerhardt JA, Cantor M, Brahmandam M, Clark JW, Namgyal C, Kawasaki T, Kinsella K, Michelini AL, Enzinger PC, Kulke MH, Ryan DP, Loda M, Fuchs CS. Ogino S, et al. Among authors: kulke mh. Clin Cancer Res. 2005 Sep 15;11(18):6650-6. doi: 10.1158/1078-0432.CCR-05-0738. Clin Cancer Res. 2005. PMID: 16166444 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page